Cadila's ZyCoV-D vaccine recommended by Indian drug regulator panel

Once approved, Zydus Cadila could be the second home-grown shot to get emergency usage clearance after Covaxin, in India. This is the first vaccine trial, adolescents have been a part of.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3iYevnH
via IFTTT